(S (NP-SBJ (NP (JJ Human) (NN T) (NN cell) (NN activation)) (PP (IN through) (NP (DT the) (JJ activation-inducer) (NN (CD69 molecule))))) (VP (VBZ enhances) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN transcription) (NN factor) (NN AP-1))))) (. .))
(S (NP-SBJ-38 (NP (DT The) (NN induction)) (PP (IN of) (NP (DT the) (NN AP-1) (NN transcription) (NN factor)))) (VP (VBZ has) (VP (VBN been) (VP (VBN ascribed) (NP (-NONE- *-38)) (PP (TO to) (NP (NP (DT the) (JJ early) (NNS events)) (VP (VBG leading) (PP (TO to) (NP (NN T) (NN cell) (NP-COOD (NP (NN differentiation)) (CC and) (NP (NN activation))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN AP-1) (NN activity))) (PP (IN in) (NP (NP (JJ human) (JJ peripheral) (NN blood) (NN T) (NNS lymphocytes)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN through) (NP (DT the) (NN activation) (NN inducer) (NN molecule) (-LRB- -LRB-) (NN AIM) (-RRB- -RRB-) (NN CD69) (NN activation) (NN pathway))))))))) (. .))
(S (NP-SBJ-39 (NN Phorbol) (NNS esters)) (VP (VBP are) (VP (VBN required) (UCP-COOD (S (NP-SBJ-40 (-NONE- *-39)) (VP (TO to) (VP (VB induce) (NP (NN (CD69 AIM)) (JJ cell-surface) (NN expression))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN for) (S (NP-SBJ (-NONE- *-40)) (VP (VBG triggering) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NN T) (NNS cells)))) (PP (IN in) (NN conjunction) (IN with) (NP (JJ anti-AIM) (NN mAb))))))))) (. .))
(S (NP-SBJ (NN Mobility) (NN shift) (NNS assays)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (NN addition)) (PP (IN of) (NP (JJ anti-AIM) (NN mAb))) (PP (TO to) (NP (JJ PMA-treated) (NN T) (NNS lymphocytes)))) (ADVP (RB markedly)) (VP (VBD enhanced) (NP (NP (DT the) (NN binding) (NN activity)) (PP (IN of) (NP (NN AP-1))) (PP (TO to) (NP (NP (PRP$ its) (JJ cognate) (NN sequence)) (, ,) (NP (DT the) (NN phorbol) (NN ester) (NN response) (NN element))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NN anti-AIM) (NN mAb)) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (DT any) (NN change)) (PP (IN in) (NP (NP (DT the) (NN binding) (NN activity)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (, ,) (NP (NP (DT a) (NN transcription) (NN factor)) (SBAR (WHNP-41 (WP$ whose) (NN activity)) (S (NP-SBJ-42 (-NONE- *T*-41)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN regulated) (NP (-NONE- *-42)) (PP (IN by) (NP-LGS (NN protein) (NN kinase) (NN C))))))))))))))) (. .))
(S (NP-SBJ-43 (NP (DT The) (NN increase)) (PP (IN in) (NP (JJ AP-1-binding) (NN activity)))) (VP (VBD was) (VP (VBN accompanied) (NP (-NONE- *-43)) (PP (IN by) (NP-LGS (NP (DT the) (JJ marked) (NN stimulation)) (PP (IN of) (NP-COOD (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NN c-fos)))) (CONJP (CC but) (RB not)) (NP (DT that) (PP (IN of) (NP (NN c-jun)))))))))) (. .))
(S (NP-SBJ (NP (NN Blockade)) (PP (IN of) (NP (DT the) (JJ DNA-binding) (NNS complexes))) (PP (IN with) (NP (DT an) (JJ anti-Fos) (NN mAb)))) (VP (VBD demonstrated) (NP (NP (DT a) (JJ direct) (NN participation)) (PP (IN of) (NP (NN c-Fos))) (PP (IN in) (NP (NP (DT the) (NN AP-1) (NNS complexes)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN anti-AIM) (NN mAb)))))))) (. .))
(S (NP-SBJ-44 (NP (JJS Most)) (PP (IN of) (NP (DT the) (NN AP-1) (NN activity)))) (VP (MD could) (VP (VB be) (VP (VBN eliminated) (NP-45 (-NONE- *-44)) (SBAR-TMP (WHADVP-46 (WRB when)) (S (NP-SBJ-47 (DT the) (NN anti-AIM) (NN mAb)) (VP (VBD was) (VP (VBN added) (NP (-NONE- *-47)) (PP (TO to) (NP (DT the) (NN culture) (NN medium))) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN cycloheximide))) (ADVP (-NONE- *T*-46)))))) (, ,) (S (NP-SBJ (-NONE- *-45)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (ADJP (FW de) (FW novo)) (NN protein) (NN synthesis)) (VP (VBZ is) (ADJP-PRD (JJ crucial) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ AP-1-binding) (NN activity)))))))))))))) (. .))
(S (NP (DT These) (NNS data)) (VP (VBP provide) (NP (DT the) (NN evidence) (SBAR (IN that) (NP-SBJ (NP (NN activation)) (PP (IN of) (NP (JJ human) (JJ peripheral) (NN blood) (NN T) (NNS cells))) (PP (IN through) (NP (DT the) (NN AIM) (NN activation) (NN pathway)))) (VP (VBP regulate) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN AP-1)))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ (DT this) (NN pathway)) (VP (VBZ appears) (PP (IN as) (NP (NP (DT a) (JJ crucial) (NN step)) (PP (IN in) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (JJ early) (NN T) (NN cell) (NN activation) (NNS events)))))))) (. .))
